R J ten Berge1, M H Raasveld, F N van Diepen, C E Hack. Show Affiliations » 1. Department of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands.
Abstract
Mesh： See more » Antithrombin III/analysisComplement ActivationComplement C3a/analysisEnzyme-Linked Immunosorbent AssayFibrinolysisGraft Rejection/therapyHumansKidney Transplantation/immunologyKidney Transplantation/physiologyMuromonab-CD3/therapeutic usePeptide Hydrolases/analysisRadioimmunoassayTime FactorsTissue Plasminogen Activator/bloodTumor Necrosis Factor-alpha/analysisTumor Necrosis Factor-alpha/metabolism
Substances： See more » Muromonab-CD3Tumor Necrosis Factor-alphaantithrombin III-protease complexComplement C3aAntithrombin IIIPeptide HydrolasesTissue Plasminogen Activator
Year: 1993 PMID： 8438416
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066